ReviewJournal of cheminformatics2026
Learnable protein representations in computational biology for predicting drug-target affinity.
Review in Journal of cheminformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
In this review, we discuss the various different types of learnable protein representations that have been used in computational biology, with a particular focus on representations that have been used in the paradigm of predicting drug-target affinity. We explore this from multiple perspectives: the source of protein information used, the training paradigms used in generating and applying such representations, and the types of (deep-learning-based) encoding or embedding methods that have been used to generate and operate on such representations. We focus on drug-target affinity due to its particular relevance and utility in the field of drug development and assessment, and we make suggestions for how drug-target affinity prediction methods development can be further improved by examining the current literature from the aforementioned perspectives. This survey thus serves as a valuable resource for researchers seeking to develop methods for predicting drug-target affinity by exploring how protein information has been used and could be used in effective ways to improve such predictions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.